Ask A Lawyer

Talk to an Pradaxa risks Lawyer for a free case review.

:
Severe Bleeding
Fatal Bleeding
Stroke
Gastrointestinal Pain
Other Injuries

Pradaxa clinical trial issues

More than 18,000 patients participated in a clinical trial comparing Pradaxa and Coumadin. Major bleeding events occurred at similar rates with both drugs.

Pradaxa Bleeding Lawsuit Information

In the clinical trial, patients taking Pradaxa had fewer strokes than those who took Coumadin. On October 19, 2010, the FDA approved Pradaxa 75 mg and 150 mg capsules for the prevention of stroke and blood clots in patients with abnormal heart rhythm or AF. Pradaxa is made by Boehringer Ingelheim Pharmaceuticals Inc. of Ridgefield, Conn.

As with other approved blood thinner drugs, bleeding, including life-threatening and fatal bleeding, was among the most common adverse reactions reported by patients treated with Pradaxa. Gastrointestinal symptoms, including stomach pain, nausea, heartburn, and bloating were also reported.

A report of about 50 cases of fatal bleeding worldwide associated with the drug surfaced in November 2011. On December 7, 2011, slightly more than one year later of approving Pradaxa— the FDA announced that despite post marketing reports of severe bleeding patients should continue to take Pradaxa.

However, during the clinical trial, 110 mg and 150 mg capsules were tested not 75 mg. How can one dose be tested in a Pradaxa clinical trial and another dose released into the pharmaceutical marketplace without testing? Is that ethical?

In an article published by the New England Journal of Medicine, AF patients taking 150 mg twice a day of Pradaxa had lower rates of hemorrhagic stroke and ischemic stroke than patients taking Coumadin.

Contact Our Pradaxa Bleeding Lawyers Today »

Conversely, while the 150 mg reduced the risks of stroke, it caused more bleeding.

What's wrong with this picture? If you or a family member has suffered severe bleeding from Pradaxa please contact Anapol Schwartz as you may be entitled to a Pradaxa bleeding lawsuit.

Home  |  Site Map  |  Privacy  |  Disclaimer  |  Copyright

Pennsylvania Pradaxa Bleeding Lawsuits at Monheit Law

© 2002-2014 All rights reserved. Monheit Law, P.C. - PA Pradaxa Bleeding Lawyers - Philadelphia Pradaxa risks Law Firm.

Address: 1368 Barrowdale Road, Jenkintown, PA 19046.  Phone: 215-840-6573  Email: Michael@Monheit.com

Pradaxa risks Attorney Disclaimer:  This website provides general information on Pradaxa Bleeding Lawsuits, Pennsylvania Pradaxa risks Lawsuits and other legal information. Nothing on this site is intended to be legal advice. The materials on this site may be considered advertising. Nothing on this site constitutes the formation of an attorney client relationship. This website is not intended to solicit clients outside the Commonwealth of Pennsylvania. In order to discuss representation, we must personally speak with you and enter into a signed, written agreement for representation. By utilizing this site, you agree to the foregoing.

Related Topics
New Articles